Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate inhibit of human recombinant EGLN-1 as substrate after 20 mins by mass spectrophotometric analysis.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
2 mg | 在庫あり | ¥ 9,000 | |||
5 mg | 在庫あり | ¥ 15,000 | |||
10 mg | 在庫あり | ¥ 22,500 | |||
25 mg | 在庫あり | ¥ 42,500 | |||
50 mg | 在庫あり | ¥ 68,500 | |||
100 mg | 在庫あり | ¥ 110,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 16,000 |
説明 | Tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate inhibit of human recombinant EGLN-1 as substrate after 20 mins by mass spectrophotometric analysis. |
分子量 | 433.93 |
分子式 | C22H28ClN3O4 |
CAS No. | 1303512-02-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.95 mg/mL (11.41 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Izilendustat 1303512-02-8 Chromatin/Epigenetic Metabolism HIF/HIF Prolyl-Hydroxylase inmmune response HIF-PH colitis prolyl hydroxylase Inhibitor HIF-2 HIFs Hypoxia-inducible factors inflammatory bowel diseases inhibit HIF- lα inhibitor